Delivery Order SPE2DB22D1103-SPE2DB24FTEB5
- Not listed
- This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $27,704.36, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $13,271.92, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
- This federal contract award is for the delivery of Eliquis 5mg tablets to the Defense Logistics Agency (DLA). The $26,698.94 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 6, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
- This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $11,558.36, was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and has a completion date of December 30, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $10,374.53, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, with an ultimate completion date of August 14, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the...
- This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The $4,658.11 firm-fixed-price delivery order was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 18, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,692.14 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $10,330.69 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 9, 2024, with an ultimate completion date of August 12, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the pharmaceutical product Eliquis 5 mg tablets, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,394.41 firm fixed-price delivery order contract has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $7,133.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a firm-fixed-price delivery order with a completion date of May 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTEB5Delivery Order
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $19,030.06, is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 22, 2024 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is part of the company's extensive portfolio of federal contract vehicles, including a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.0k | 1/19/24 |